U 3618 (Vantin 200 mg)

Generic Name: cefpodoxime

Pill imprint U 3618 has been identified as Vantin 200 mg.

Vantin is used in the treatment of skin infection; bladder infection; bronchitis; gonococcal infection, disseminated; otitis media (and more), and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Vantin 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for U 3618

Vantin 200 mg U 3618
Vantin 200 mg U 3618
Vantin
Generic Name:
cefpodoxime
Imprint:
U 3618
Strength:
200 mg
Color:
Red
Size:
14.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Third generation cephalosporins
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC):
00009-3618
Inactive Ingredients:
carboxymethylcellulose calcium
FD&C Yellow No. 6
hydroxypropyl cellulose
hypromellose
lactose monohydrate
magnesium stearate
propylene glycol
sodium lauryl sulfate
titanium dioxide
FD&C Red No. 40
carnauba wax
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
55289-0390 PDRX Pharmaceuticals Inc (repackager)
54569-4783 A S Medication Solutions LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)